Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
D000906:Antibodies / Q000032:analysis*; D005500:Follow-Up Studies; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008457:Measles / Q000276:immunology*; D008458:Measles Vaccine / Q000008:administration & dosage*; D009107:Mumps / Q000453:epidemiology / Q000276:immunology*; D009108:Mumps Vaccine / Q000008:administration & dosage*; D009500:Neutralization Tests; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D012572:School Health Services; D013997:Time Factors; D014611:Vaccination; D014613:Vaccines, Attenuated
D000906:Antibodies; D008458:Measles Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated